April 05, 2024
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.
Eugia US recalled one lot of methocarbamol injection, 100mg/mL in single-dose, 10mL vials on March 28, 2024, after unidentified particles were found in some vials from the lot. It is used to treat musculoskeletal conditions such as carpal tunnel syndrome, muscle strains and tendinitis. If injected, particulates may cause irritation and inflammation at the injection site, as well as blood clots or blood vessel blockages that could result in life-threatening conditions. For additional information, see the FDA’s notice.
Last updated: April 05, 2024